Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

(2022) Natalie Gukasyan et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Abnormal dynamic functional connectivity during fear extinction learning in PTSD and anxiety disorders

(2022) Zhenfu Wen et al.   MOLECULAR PSYCHIATRY

Exosomal transfer of microRNA-590-3p between renal tubular epithelial cells after renal ischemia-reperfusion injury regulates autophagy by targeting TRAF6

(2022) Yimeng Chen et al.   CHINESE MEDICAL JOURNAL

A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain

(2021) Nakul Ravi Raval et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Antidepressant drugs act by directly binding to TRKB neurotrophin receptors

(2021) Plinio C. Casarotto et al.   CELL

Neurosteroids and Neurotrophic Factors: What Is Their Promise as Biomarkers for Major Depression and PTSD?

(2021) Felipe Borges Almeida et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Anti-PTSD Effects of Hypidone Hydrochloride (YL-0919): A Novel Combined Selective 5-HT Reuptake Inhibitor/5-HT1A Receptor Partial Agonist/5-HT6 Receptor Full Agonist

(2021) Wen-Gang Liu et al.   Frontiers in Pharmacology

Trial of Psilocybin versus Escitalopram for Depression

(2021) Robin Carhart-Harris et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear

(2021) Sven Melker Hagsäter et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo

(2021) Ling-Xiao Shao et al.   NEURON

Cannabidiol and Sertraline Regulate Behavioral and Brain Gene Expression Alterations in an Animal Model of PTSD

(2021) Ani Gasparyan et al.   Frontiers in Pharmacology

Amygdala DCX and blood Cdk14 are implicated as cross-species indicators of individual differences in fear, extinction, and resilience to trauma exposure

(2021) M. E. Maheu et al.   MOLECULAR PSYCHIATRY

Unexpected BrdU inhibition on astrocyte-to-neuron conversion

(2021) Gong Chen et al.   Neural Regeneration Research

Randomized controlled experimental study of hydrocortisone and D-cycloserine effects on fear extinction in PTSD

(2021) Sabra S. Inslicht et al.   NEUROPSYCHOPHARMACOLOGY

Neurobiology of BDNF in fear memory, sensitivity to stress, and stress-related disorders

(2020) Michael Notaras et al.   MOLECULAR PSYCHIATRY

Emotions and brain function are altered up to one month after a single high dose of psilocybin

(2020) Frederick S. Barrett et al.   Scientific Reports

Reviewing the Potential of Psychedelics for the Treatment of PTSD

(2020) Erwin Krediet et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Distance-dependent regulation of NMDAR nanoscale organization along hippocampal neuron dendrites

(2020) Joana S. Ferreira et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice

(2020) Anna U. Odland et al.   BEHAVIOURAL BRAIN RESEARCH

A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice

(2020) Sebastiano A. Torrisi et al.   Neurobiology of Stress

Increased 5-HT2C receptor editing predisposes to PTSD-like behaviors and alters BDNF and cytokines signaling

(2019) Mathilde Règue et al.   Translational Psychiatry

Structural and Functional Remodeling of Amygdala GABAergic Synapses in Associative Fear Learning

(2019) Yu Kasugai et al.   NEURON

Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders

(2019) Simone B. Sartori et al.   PHARMACOLOGY & THERAPEUTICS

Smaller Hippocampal Volume in Posttraumatic Stress Disorder: A Multisite ENIGMA-PGC Study: Subcortical Volumetry Results From Posttraumatic Stress Disorder Consortia

(2018) Mark W. Logue et al.   BIOLOGICAL PSYCHIATRY

Psychedelics Promote Structural and Functional Neural Plasticity

(2018) Calvin Ly et al.   Cell Reports

Synaptic Plasticity in PTSD and associated Comorbidities: The Function and Mechanism for Diagnostics and Therapy

(2018) Mei He et al.   CURRENT PHARMACEUTICAL DESIGN

Mechanisms of fear learning and extinction: synaptic plasticity–fear memory connection

(2018) Natalia V. Luchkina et al.   PSYCHOPHARMACOLOGY

Rodent models of impaired fear extinction

(2018) Nicolas Singewald et al.   PSYCHOPHARMACOLOGY

Reconsolidation/destabilization, extinction and forgetting of fear memory as therapeutic targets for PTSD

(2018) Satoshi Kida   PSYCHOPHARMACOLOGY

Post-Traumatic Stress Disorder

(2017) Arieh Shalev et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: a network meta-analysis

(2017) Andrea Cipriani et al.   PSYCHOLOGICAL MEDICINE

TrkB dependent adult hippocampal progenitor differentiation mediates sustained ketamine antidepressant response

(2017) Zhenzhong Ma et al.   Nature Communications

Pharmacotherapy for post-traumatic stress disorder: Systematic review and meta-analysis

(2015) Mathew Hoskins et al.   BRITISH JOURNAL OF PSYCHIATRY

Anxiolytic effects of ketamine in animal models of posttraumatic stress disorder

(2014) Li-Ming Zhang et al.   PSYCHOPHARMACOLOGY

Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning

(2013) Briony J. Catlow et al.   EXPERIMENTAL BRAIN RESEARCH

Fear Erasure in Mice Requires Synergy Between Antidepressant Drugs and Extinction Training

(2011) N. N. Karpova et al.   SCIENCE